Gain Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Gain Therapeutics

10/11/2022 23:29

* Gain Therapeutics Inc  GANX.OQ  reported a quarterly
adjusted
loss of 38 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 46 cents per share.
    * Reported revenue was zero​; analysts expected $57.75
thousand. 
    * Gain Therapeutics Inc's reported EPS for the quarter was a
loss
of 38 cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Gain Therapeutics Inc shares had fallen by 5.8% this
quarter and
lost 43.5% so far this year.
    * The company reported a quarterly loss of $4.56 million.
    * Wall Street's median 12-month price target for Gain
Therapeutics
Inc is $21.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:28 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.46          -0.38          Beat
 Jun. 30 2022      -0.31          -0.43          Missed
 Mar. 31 2022      -0.37          -0.28          Beat
 Dec. 31 2021      -0.49          -0.32          Beat